JP2024536869A5 - - Google Patents
Info
- Publication number
- JP2024536869A5 JP2024536869A5 JP2024518884A JP2024518884A JP2024536869A5 JP 2024536869 A5 JP2024536869 A5 JP 2024536869A5 JP 2024518884 A JP2024518884 A JP 2024518884A JP 2024518884 A JP2024518884 A JP 2024518884A JP 2024536869 A5 JP2024536869 A5 JP 2024536869A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- cycloalkyl
- pharmaceutically acceptable
- unsubstituted
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163248566P | 2021-09-27 | 2021-09-27 | |
| US63/248,566 | 2021-09-27 | ||
| US202163273422P | 2021-10-29 | 2021-10-29 | |
| US63/273,422 | 2021-10-29 | ||
| US202263367546P | 2022-07-01 | 2022-07-01 | |
| US63/367,546 | 2022-07-01 | ||
| PCT/US2022/077001 WO2023049887A1 (en) | 2021-09-27 | 2022-09-26 | Imidazopyridazine il-17 inhibitor compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024536869A JP2024536869A (ja) | 2024-10-08 |
| JP2024536869A5 true JP2024536869A5 (https=) | 2025-09-19 |
Family
ID=83692741
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024518884A Pending JP2024536869A (ja) | 2021-09-27 | 2022-09-26 | イミダゾピリダジンｉｌ－１７阻害剤化合物 |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US12173007B2 (https=) |
| EP (1) | EP4408847A1 (https=) |
| JP (1) | JP2024536869A (https=) |
| KR (1) | KR20240082369A (https=) |
| AU (1) | AU2022349687A1 (https=) |
| CA (1) | CA3233408A1 (https=) |
| CL (1) | CL2024000867A1 (https=) |
| CO (1) | CO2024003723A2 (https=) |
| DO (1) | DOP2024000051A (https=) |
| IL (1) | IL311751A (https=) |
| JO (1) | JOP20240059A1 (https=) |
| MX (1) | MX2024003772A (https=) |
| PE (1) | PE20240935A1 (https=) |
| TW (1) | TW202330530A (https=) |
| UY (1) | UY39958A (https=) |
| WO (1) | WO2023049887A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL311751A (en) | 2021-09-27 | 2024-05-01 | Janssen Pharmaceutica Nv | IL-17 imidazopyridazine inhibitory compounds |
| CN118401519A (zh) | 2021-10-25 | 2024-07-26 | 拓臻制药公司 | 作为glp-1r激动剂的化合物 |
| TW202430165A (zh) | 2022-12-02 | 2024-08-01 | 丹麥商理奧藥品公司 | Il-17之小分子調節劑 |
| CN120731202A (zh) * | 2023-01-30 | 2025-09-30 | 戴斯阿尔法公司 | 基于苯并咪唑和氮杂-苯并咪唑的il-17a调节剂及其用途 |
| CN121311483A (zh) * | 2023-03-28 | 2026-01-09 | 詹森药业有限公司 | 含内酰胺的咪唑并哒嗪il-17抑制剂化合物 |
| EP4568664B1 (en) | 2023-04-07 | 2026-04-01 | Terns Pharmaceuticals, Inc. | Combination comprising a thr-beta agonist and a glp-1r agonist for use in treating obesity |
| WO2024215597A1 (en) * | 2023-04-11 | 2024-10-17 | Dice Alpha, Inc. | Substituted 6-imidazopyridazine il-17a modulators and uses thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI752400B (zh) | 2019-01-07 | 2022-01-11 | 美商美國禮來大藥廠 | Il-17a抑制劑 |
| GB201909190D0 (en) | 2019-06-26 | 2019-08-07 | Ucb Biopharma Sprl | Therapeutic agents |
| PE20230469A1 (es) | 2020-04-30 | 2023-03-14 | Janssen Pharmaceutica Nv | Imidazopiridazinas como moduladores de il-17 |
| WO2023025783A1 (en) | 2021-08-23 | 2023-03-02 | Leo Pharma A/S | Small molecule modulators of il-17 |
| IL311751A (en) | 2021-09-27 | 2024-05-01 | Janssen Pharmaceutica Nv | IL-17 imidazopyridazine inhibitory compounds |
| CN116143777A (zh) | 2021-11-04 | 2023-05-23 | 四川海思科制药有限公司 | 一种可抑制il-17a的杂环化合物及其用途 |
-
2022
- 2022-09-26 IL IL311751A patent/IL311751A/en unknown
- 2022-09-26 WO PCT/US2022/077001 patent/WO2023049887A1/en not_active Ceased
- 2022-09-26 TW TW111136301A patent/TW202330530A/zh unknown
- 2022-09-26 PE PE2024000594A patent/PE20240935A1/es unknown
- 2022-09-26 EP EP22790174.1A patent/EP4408847A1/en active Pending
- 2022-09-26 CA CA3233408A patent/CA3233408A1/en active Pending
- 2022-09-26 UY UY0001039958A patent/UY39958A/es unknown
- 2022-09-26 US US17/935,360 patent/US12173007B2/en active Active
- 2022-09-26 KR KR1020247013352A patent/KR20240082369A/ko active Pending
- 2022-09-26 AU AU2022349687A patent/AU2022349687A1/en active Pending
- 2022-09-26 MX MX2024003772A patent/MX2024003772A/es unknown
- 2022-09-26 JP JP2024518884A patent/JP2024536869A/ja active Pending
-
2024
- 2024-03-14 DO DO2024000051A patent/DOP2024000051A/es unknown
- 2024-03-22 CO CONC2024/0003723A patent/CO2024003723A2/es unknown
- 2024-03-25 CL CL2024000867A patent/CL2024000867A1/es unknown
- 2024-03-26 JO JOJO/P/2024/0059A patent/JOP20240059A1/ar unknown
- 2024-10-04 US US18/906,207 patent/US20250109137A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024536869A5 (https=) | ||
| JP2024536863A5 (https=) | ||
| JP2023524018A5 (https=) | ||
| JP2024050527A5 (https=) | ||
| JP2023523770A5 (https=) | ||
| JP2024100974A5 (https=) | ||
| JP2022519636A5 (https=) | ||
| JP2024536868A5 (https=) | ||
| JP2024178191A5 (https=) | ||
| JP2818820B2 (ja) | 抗炎症剤としての３−アリール−２−イソオキサゾリン類 | |
| JP2024536862A5 (https=) | ||
| HRP20100020T1 (hr) | Novi derivati hidantoina za liječenje opstruktivnih bolesti dišnih putova | |
| JP4020954B2 (ja) | 疾患の処置のためのスルホンアミド誘導体 | |
| JP2012521994A5 (https=) | ||
| JP2017518959A5 (https=) | ||
| JP2022544714A5 (https=) | ||
| JP2023515617A5 (https=) | ||
| JP2021535174A5 (https=) | ||
| JP2018519323A5 (https=) | ||
| JP2014530900A5 (https=) | ||
| JP2008505171A5 (https=) | ||
| JP2009534406A5 (https=) | ||
| WO2008006509A1 (en) | Derivatives of 1-phenyl-2-pyridynyl alkylene alcohols as phosphodiesterase inhibitors | |
| JP2021535177A5 (https=) | ||
| JP2023520924A5 (https=) |